Immuron Ltd
Develops oral antibodies from bovine colostrum for digestive and immune health.
IMRN | NDAQ
Overview
Corporate Details
- ISIN(s):
- US45254U1016 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 62 LYGON STREET, 3053 CARLTON, VICTORIA
- Website:
- https://www.immuron.com.au
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on developing and commercializing a novel class of orally delivered, targeted polyclonal antibodies. The company's proprietary, patent-protected technology platform utilizes immunoglobulins (IgG) derived from hyper-immune bovine colostrum to address significant unmet medical needs. Immuron's primary focus is on gastrointestinal health, immune defense, and digestive disorders. Its portfolio of commercialized products includes Travelan®, for reducing the risk of travellers' diarrhoea; Protectyn®, for supporting gut and liver function; and ProIBS®, for the relief of symptoms related to Irritable Bowel Syndrome.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Immuron Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Immuron Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Immuron Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
